Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Kamada Ltd. Director's Dealing 2026

Mar 23, 2026

6874_rns_2026-03-23_d7486f3b-3442-424b-a90b-7e5e1251c322.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

E

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

OMB APPROVAL

OMB Number: 3235-0104

Estimated average

burden hours

per response

0.5

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person* Davidi Ishay 2. Date of Event Requiring Statement (Month/Day/Year) 03/23/2026 3. Issuer Name and Ticker or Trading Symbol KAMADA LTD [ KMDA ] 3a. Foreign Trading Symbol
(Last) (First) (Middle)
94 YIGAL ALON ST., ALON TOWER 2.
(Street)
TEL AVIV 6789139
(City) (State) (Zip/Postal Code)
ISRAEL
(Country)
Table I – Non-Derivative Securities Beneficially Owned
--- --- ---
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)
Ordinary Shares 22,084,287 I
Table II – Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
--- --- ---
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)
Date Exercisable Expiration Date
Options to purchase Ordinary Shares(2) 03/25/2021 09/25/2026
Options to purchase Ordinary Shares(2) 03/25/2022 09/25/2026
Options to purchase Ordinary Shares(2) 03/25/2023 09/25/2026
Options to purchase Ordinary Shares(2) 12/22/2023 06/22/2029
Options to purchase Ordinary Shares(2) 03/25/2024 09/25/2026
Options to purchase Ordinary Shares(2) 12/22/2024 06/22/2029
Options to purchase Ordinary Shares(2) 12/22/2025 06/22/2029
Options to purchase Ordinary Shares(2) 12/22/2026 06/22/2029

Explanation of Responses:

  1. FIMI Opportunity Fund 6, L.P., FIMI Israel Opportunity Fund 6, Limited Partnership, FIMI Opportunity 7, L.P. and FIMI Israel Opportunity Fund 7, Limited Partnership
  2. These options to purchase ordinary shares are exercisable using a net-exercise method
  3. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

/s/ Ishay Davidi

03/23/2026

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

  • If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.